This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Teneobio, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 15 
1 out of 1 Years Active: 2026
Title: Norris Lam - Innovator in Chimeric Antigen Receptors
Introduction
Norris Lam is an inventor based in Bethesda, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors (CARs) targeting B-cell Maturation Antigen (BCMA). Although he currently holds no granted patents, his work is noteworthy for its potential impact on cancer treatment.
Latest Patent Applications
Norris Lam's latest patent application is titled "ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS." This application provides chimeric antigen receptors that have antigen specificity for B-cell Maturation Antigen (BCMA). It also includes related nucleic acids, recombinant expression vectors, host cells, populations of cells, and pharmaceutical compositions related to the CARs. Furthermore, the application outlines methods for treating or preventing cancer in mammals.
Conclusion
Norris Lam's innovative work in the field of chimeric antigen receptors highlights his commitment to advancing cancer therapies. His contributions, although not yet reflected in granted patents, demonstrate the potential for significant advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile